Clalit drug co-payments to be reduced for patients

Patient co-payments of 62 prescription medications not included in the basket of medical technologies are being reduced by a total of NIS 24 million by Clalit Health Services, the largest health fund.
The decision to reduce the amount of money paid by the patient was reached by Clalit, Health Ministry Deputy Health Minister Ya’acov Litzman and his (outgoing) deputy director-general in charge of health fund supervision, Dr Yoel Lipschitz.
The ministry said some 150,000 Clalit member will benefit.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy